Drug Survival Analysis Is Not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis
- PMID: 27765164
- DOI: 10.1016/j.ad.2016.09.001
Drug Survival Analysis Is Not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis
Comment in
-
Comment on "Drug survival analysis is not a good method for assessing the safety or effectiveness of systemic therapies in psoriasis".Actas Dermosifiliogr. 2017 Sep;108(7):695-696. doi: 10.1016/j.ad.2017.03.012. Epub 2017 May 11. Actas Dermosifiliogr. 2017. PMID: 28504083 English, Spanish. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
